Boule Diagnostics AB (publ) (STO:BOUL)
Sweden · Delayed Price · Currency is SEK 5.70
-0.10 (-1.72%)
Sep 18, 2025, 4:58 PM CET
Boule Diagnostics AB Revenue
Boule Diagnostics AB had revenue of 129.30M SEK in the quarter ending June 30, 2025, a decrease of -5.62%. This brings the company's revenue in the last twelve months to 515.86M, down -9.90% year-over-year. In the year 2024, Boule Diagnostics AB had annual revenue of 558.46M, down -2.25%.
Revenue (ttm)
515.86M
Revenue Growth
-9.90%
P/S Ratio
0.44
Revenue / Employee
2.58M
Employees
200
Market Cap
225.23M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 558.46M | -12.87M | -2.25% |
| Dec 31, 2023 | 571.33M | 23.24M | 4.24% |
| Dec 31, 2022 | 548.09M | 84.74M | 18.29% |
| Dec 31, 2021 | 463.34M | 62.89M | 15.70% |
| Dec 31, 2020 | 400.46M | -98.46M | -19.73% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Swedish Orphan Biovitrum AB | 26.97B |
| Sectra AB | 3.37B |
| Getinge AB | 35.50B |
| Camurus AB | 2.27B |
| Medicover AB | 25.22B |
| Asker Healthcare Group AB | 15.88B |
| BioArctic AB | 1.86B |
| AddLife AB | 10.44B |
Boule Diagnostics AB News
- 2 months ago - Boule Diagnostics AB (OSTO:BOUL) Q2 2025 Earnings Call Highlights: Navigating Challenges with ... - GuruFocus
- 7 months ago - Q4 2024 Boule Diagnostics AB Earnings Call Transcript - GuruFocus
- 11 months ago - Q3 2024 Boule Diagnostics AB Earnings Call Transcript - GuruFocus